Abstract: In alternative embodiments, provided are methods for treating, ameliorating or protecting (preventing) congestive heart failure (CHF) or a diabetes-related cardiac dysfunction, comprising: providing a urocortin 2-encoding and/or a urocortin 3-encoding nucleic acid, transcript or message, or gene, operatively linked to a transcriptional regulatory sequence, optionally contained in an expression vehicle or a vector such as an adeno-associated virus (AAV), e.g., an AAV8 serotype; and administering to an individual or a patient in need thereof, such as a type 2 diabetic (T2DM), e.g., by IV administration, thereby treating, ameliorating or protecting against (preventing) the T2DM and/or the diabetes-related cardiac dysfunction in the individual or patient.

Abstract: An olefin-metathesis catalyst is provided. The olefin-metathesis catalyst includes a magnetic carrier, a polymer having formula (I) grafted on the magnetic carrier, and a ruthenium complex loaded on the polymer. A method for preparing low-molecular-weight nitrile butadiene rubber is also provided. In formula (I), one of X, Y and Z is nitrogen atom, the others are carbon atoms, R1 and R2, independently, include hydrogen, ester group, C1-10 alkyl group, C3-8 cycloalkyl group, 4-ring to 8-ring heterocycloalkyl or C6-10 aryl group, R3 includes hydrogen or C1-10 alkyl group, m ranges from 10 to 2,000, and n ranges from 0 to 1,000.

Abstract: A supporting device is used to support a display. The supporting device includes two fixing parts, two supporting arms, and a base. The base can be made by bending a rod in a plane. The fixing parts are fixed with the display. Each supporting arm includes a connecting portion and an assembly portion. The connecting portion connects an end of the fixing part. The assembly portion is fixed with the base. An extending direction of the supporting arm is substantially perpendicular to the plane with the rod.

Abstract: An electronic device with supporting structure includes a connection member, a back shell, two first fixing portions, and two second fixing portions. The connection member is attached to the supporting structure and defines two connection holes. Each connection hole includes a first through hole and a second through hole. A diameter of the second through hole is greater than that of the first through hole. The two first fixing portions are protruding from the back shell and are slidable between the second through holes and the first through holes. The two second fixing portions are attached to the two first fixing portions and can pass through the two second through holes. The connection member can prevent the two second fixing portions passing through the first through holes when the first fixing portions slide to the first through holes.

Abstract: The invention provides methods for treating, ameliorating or protecting (preventing) an individual or a patient having or at risk of having heart disease or heart failure, or decreased cardiac function, comprising: providing a cyclic adenosine monophosphate-incompetent (cAMP-incompetent) adenylyl cyclase type 6 (AC6) protein or polypeptide (also called “an AC6mut”), or an AC6mut-encoding nucleic acid or a gene operatively linked to a transcriptional regulatory sequence.

Abstract: A method for controlling a powered wheelchair is disclosed. The method may comprise receiving first information from at least one user sensor coupled to a user of the wheelchair, said first information indicating the movement of the user; receiving second information from a reference sensor coupled to the wheelchair, said second information indicating the movement of the wheelchair; using the first information and the second information to prepare at least one instruction to move the wheelchair; and using the at least one instruction to move the wheelchair.

Abstract: The present invention relates to a novel use of substance P. The substance P of the present invention exhibits effects of decreasing microglia activity, decreasing proinflammatory cytokines, inhibiting apoptosis, etc. The substance P of the present invention effectively treats degenerative central nervous system diseases or disorders such as a spinal cord injury caused by a traumatic injury (flexion injury, vertical compression injury, hyperextension injury, flexion-rotation injury) and by a non-traumatic injury (vascular dysfunction, arthritis, or degenerative arthritis), Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, depressive disorder, epilepsy, etc.

Abstract: A method of providing protection against pneumococcal infection in a subject is disclosed. The method includes steps of administering to the subject a composition that includes combination of three recombinant pneumococcal neuraminidases: NanA, NanB, and NanC of S. pneumoniae strains CGSP14, wherein administration of the recombinant pneumococcal neuraminidases elicits an immune response to S. pneumoniae, and treats the subject. In one embodiment, the method further includes a step of adding adjuvants to enhance the immune response. The method also includes a step of using passive antibodies, wherein said passive antibodies are anti-neuraminidase antibodies generated from neuraminidases-immunized humanized animals: NanA, NanB, and NanC. Meanwhile, this invention also provides a method for the molecular diagnosis of pneumococcal infection.

Abstract: An electronic billboard includes a base, bracket, a display and a touch device. The bracket is removable and mounted to the base. The display is removable and mounted to the bracket. The display includes a slot and a receiving portion configured to receive a host. The touch device is received in the slot.

Abstract: An electronic device with supporting structure includes a connection member, a back shell, two first fixing portions, and two second fixing portions. The connection member is attached to the supporting structure and defines two connection holes. Each connection hole includes a first through hole and a second through hole. A diameter of the second through hole is greater than that of the first through hole. The two first fixing portions are protruding from the back shell and are slidable between the second through holes and the first through holes. The two second fixing portions are attached to the two first fixing portions and can pass through the two second through holes. The connection member can prevent the two second fixing portions passing through the first through holes when the first fixing portions slide to the first through holes.

Abstract: A method of providing protection against pneumococcal infection in a subject is disclosed. The method includes steps of administering to the subject a composition that includes combination of three recombinant pneumococcal neuraminidases: NanA, NanB, and NanC of S. pneumoniae strains CGSP14, wherein administration of the recombinant pneumococcal neuraminidases elicits an immune response to S. pneumoniae, and treats the subject. In one embodiment, the method further includes a step of adding adjuvants to enhance the immune response. The method also includes a step of using passive antibodies, wherein said passive antibodies are anti-neuraminidase antibodies generated from neuraminidases-immunized humanized animals: NanA, NanB, and NanC. Meanwhile, this invention also provides a method for the molecular diagnosis of pneumococcal infection.

Abstract: In alternative embodiments, the invention provides methods for treating, ameliorating or protecting (preventing) an individual or a patient against a disease, an infection or a condition responsive to an increased paracrine polypeptide level in vivo comprising: providing a paracrine polypeptide-encoding nucleic acid or gene operatively linked to a transcriptional regulatory sequence; or an expression vehicle, a vector, a recombinant virus, or equivalent, having contained therein a paracrine-encoding nucleic acid or gene, and the expression vehicle, vector, recombinant virus, or equivalent can express the paracrine-encoding nucleic acid or gene in a cell or in vivo; and administering or delivering the paracrine polypeptide-encoding nucleic acid or gene operatively linked to a transcriptional regulatory sequence, or the expression vehicle, vector, recombinant virus, or equivalent, to an individual or a patient in need thereof, thereby treating, ameliorating or protecting (preventing) the individual or patient a

Abstract: A capacitor and a manufacturing method thereof are provided. Two electrodes are disposed opposite to each other. Two electrode protection layers are respectively disposed on inner sides of the electrodes and include carbon particles each covered and bonded with a polymer shell. Active carbon layers are disposed on opposite inner sides of the electrode protection layers. The separator is disposed between the active carbon layers. The electrolyte fills between the electrode protection layers. The polymer shells of each electrode protection layer are bonded to the surface of the corresponding electrode by first and second functional groups. The first functional groups include thiol groups. The second functional groups include epoxy groups or carboxylic groups. The electrode protection layers serve as adhesion layers between the active carbon layers and the electrodes, and protect the electrodes from being corroded by the acid electrolyte solution.

Abstract: A method of providing protection against pneumococcal infection in a subject is disclosed. The method includes steps of administering to the subject a composition that includes combination of three recombinant pneumococcal neuraminidases: NanA, NanB, and NanC of S. pneumoniae strains CGSP14, wherein administration of the recombinant pneumococcal neuraminidases elicits an immune response to S. pneumoniae, and treats the subject. In one embodiment, the method further includes a step of adding adjuvants to enhance the immune response. The method also includes a step of using passive antibodies, wherein said passive antibodies are anti-neuraminidase antibodies generated from neuraminidases-immunized humanized animals: NanA, NanB, and NanC. Meanwhile, this invention also provides a method for the molecular diagnosis of pneumococcal infection.

Abstract: The disclosure provides a lubricating oil composition and method for manufacturing the same. The lubricating oil composition substantially consists of a base lubricant oil, and an organic-inorganic composite particle uniformly dispersed in the base lubricant oil. This lubricating oil composition is applicable to a sliding section or sliding member of an automotive internal combustion engine or power transmission apparatus to significantly reduce friction coefficient, temperature of oil and wear rate.

Abstract: A centrifugal fan is disclosed. The centrifugal fan includes a fan device and a case. The fan device includes an impeller and a plurality of blades, wherein the plurality of blades are mounted separately around the impeller. The case is provided to allow the fan device to be disposed and to rotate inside it. The case includes a top cover, a bottom cover, and a side wall. The side wall is mounted between the top cover and the bottom cover. The side wall includes a fixed part and a deformable part. The fixed part is connected with the top cover and the bottom cover, and the deformable part is connected with the fixed part.

Abstract: A capacitor and a manufacturing method thereof are provided. Two electrodes are disposed opposite to each other. Two electrode protection layers are respectively disposed on inner sides of the electrodes and include carbon particles each covered and bonded with a polymer shell. Active carbon layers are disposed on opposite inner sides of the electrode protection layers. The separator is disposed between the active carbon layers. The electrolyte fills between the electrode protection layers. The polymer shells of each electrode protection layer are bonded to the surface of the corresponding electrode by first and second functional groups. The first functional groups include thiol groups. The second functional groups include epoxy groups or carboxylic groups. The electrode protection layers serve as adhesion layers between the active carbon layers and the electrodes, and protect the electrodes from being corroded by the acid electrolyte solution.

Abstract: A self-assembly coating material including carbon particles and polymer shells is provided. The polymer shells respectively cover and are bonded to the carbon particles, wherein each polymer shell has both a first functional group for adsorbing on a surface of a substrate and a second functional group for self cross-linking. The first functional groups include thiol groups. The second functional groups include epoxy groups or carboxylic groups. The self-assembly coating material can be applied to a metal substrate to form a heat dissipation layer.

Abstract: A method of providing protection against pneumococcal infection in a subject is disclosed. The method includes steps of administering to the subject a composition that includes combination of three recombinant pneumococcal neuraminidases: NanA, NanB, and NanC of S. pneumoniae strains CGSP14, wherein administration of the recombinant pneumococcal neuraminidases elicits an immune response to S. pneumoniae, and treats the subject. In one embodiment, the method further includes a step of adding adjuvants to enhance the immune response. The method also includes a step of using passive antibodies, wherein said passive antibodies are anti-neuraminidase antibodies generated from neuraminidases-immunized humanized animals: NanA, NanB, and NanC. Meanwhile, this invention also provides a method for the molecular diagnosis of pneumococcal infection.